Terms: = Thyroid cancer AND EBF1, COE1, 1879, ENSG00000164330, Q9UH73, OLF1, O/E-1, EBF
19 results:
1. Contralateral Low-to-Intermediate Suspicion Nodule Is Not a Contraindication for Lobectomy in Patients with Papillary thyroid Carcinoma.
Pak SJ; Kwon D; Kim BC; Cho JW; Kim WW; Lee YM; Sung TY; Baek JH; Kim WG; Kim WB; Chung KW
Thyroid; 2023 Nov; 33(11):1339-1348. PubMed ID: 37624735
[No Abstract] [Full Text] [Related]
2. Ectopic bone formation in thyroid gland: report of sixteen cases and comprehensive literature review.
Sogutcu N; Akbulut S; Sari A; Yavuz R; Yagmur Y; Colak C
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):988-998. PubMed ID: 36808344
[TBL] [Abstract] [Full Text] [Related]
3. LINC00261 regulates ebf1 to suppress malignant progression of thyroid cancer.
Fu XD; Liu CY; Liu YL; Su DW; Chi NN; Zhang JL; Wei WW
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7626-7634. PubMed ID: 34982424
[TBL] [Abstract] [Full Text] [Related]
4. Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program.
Vakharia PP; Kelm RC; Orrell KA; Patel KR; Singam V; Ali Y; Rastogi S; Yousif R; Rangel SM; West DP; Nardone B
Int J Dermatol; 2020 Apr; 59(4):463-468. PubMed ID: 31971260
[TBL] [Abstract] [Full Text] [Related]
5. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract] [Full Text] [Related]
6. Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer.
Tsirona S; Vlassopoulou V; Tzanela M; Rondogianni P; Ioannidis G; Vassilopoulos C; Botoula E; Trivizas P; Datseris I; Tsagarakis S
Clin Endocrinol (Oxf); 2014 Mar; 80(3):459-63. PubMed ID: 23895145
[TBL] [Abstract] [Full Text] [Related]
7. Diagnostic performance of gray-scale US and elastography in solid thyroid nodules.
Moon HJ; Sung JM; Kim EK; Yoon JH; Youk JH; Kwak JY
Radiology; 2012 Mar; 262(3):1002-13. PubMed ID: 22357900
[TBL] [Abstract] [Full Text] [Related]
8. Ectopic bone formation and extramedullary hematopoiesis in the thyroid gland: report of a case and literature review.
Akbulut S; Yavuz R; Akansu B; Sogutcu N; Arikanoglu Z; Basbug M
Int Surg; 2011; 96(3):260-5. PubMed ID: 22216706
[TBL] [Abstract] [Full Text] [Related]
9. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma.
Lewinshtein D; Gulati R; Nelson PS; Porter CR
BJU Int; 2012 Mar; 109(5):706-12. PubMed ID: 21883828
[TBL] [Abstract] [Full Text] [Related]
10. thyroid surgery in octogenarians is associated with higher complication rates.
Mekel M; Stephen AE; Gaz RD; Perry ZH; Hodin RA; Parangi S
Surgery; 2009 Nov; 146(5):913-21. PubMed ID: 19744461
[TBL] [Abstract] [Full Text] [Related]
11. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
[TBL] [Abstract] [Full Text] [Related]
12. thyroid cancer and multiple primary tumors in the SEER cancer registries.
Ronckers CM; McCarron P; Ron E
Int J Cancer; 2005 Nov; 117(2):281-8. PubMed ID: 15880372
[TBL] [Abstract] [Full Text] [Related]
13. Study of anti-striational and anti-thyroid antibodies in patients with myasthenia gravis.
Cojocaru IM; Cojocaru M; Muşuroi C
Rom J Intern Med; 2000-2001; 38-39():111-20. PubMed ID: 15529579
[TBL] [Abstract] [Full Text] [Related]
14. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
[TBL] [Abstract] [Full Text] [Related]
15. Salivary gland cancer in the United States.
Sun EC; Curtis R; Melbye M; Goedert JJ
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1095-100. PubMed ID: 10613342
[TBL] [Abstract] [Full Text] [Related]
16. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
[TBL] [Abstract] [Full Text] [Related]
17. cancer incidence in a population potentially exposed to radium-226 at Dalgety Bay, Scotland.
Black RJ; Sharp L; Finlayson AR; Harkness EF
Br J Cancer; 1994 Jan; 69(1):140-3. PubMed ID: 8286196
[TBL] [Abstract] [Full Text] [Related]
18. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
Henry-Amar M
Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
[TBL] [Abstract] [Full Text] [Related]
19. Second primary cancers following colon and rectal cancer in Osaka, Japan.
Tanaka H; Hiyama T; Hanai A; Fujimoto I
Jpn J Cancer Res; 1991 Dec; 82(12):1356-65. PubMed ID: 1778758
[TBL] [Abstract] [Full Text] [Related]